Hydrogen peroxide upregulates TNF-related apoptosis-inducing ligand (TRAIL) expression in human astroglial cells, and augments apoptosis of T cells

Yonsei Medical Journal

Volumn 47, Issue 4, 2006, Pages 551-557

  Kwon, Dacho ^a   Choi, In Hong ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Astroglial cells; Cyclosporin A; Hydrogen peroxide; Neuroimmunology; Oxidative stress; TRAIL

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; FREE RADICAL; HYDROGEN PEROXIDE; OXYGEN RADICAL; RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; BRAIN REGION; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MODULATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

EID: 33748328138     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.4.551     Document Type: Article

References (32)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-82.
2. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-8.
3. Mariani SM, Matiba B, Armandola EA, Krammer PH. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 1997; 137:221-9.
4. Wajant H, Johannes FJ, Haas F, Siemienski K, Schwenzer R, Schubert G, et al. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/ Apo2-mediated cell death but not gene induction. Curr Biol 1998;8:113-6.
5. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997;276:111-3.
6. Wang Q, Ji Y, Wang X, Evers BM. Isolation and molecular characterization of the 5′-upstream region of the human TRAIL gene. Biochem Biophys Res Commun 2000;276:466-71.
7. Frank S, Kohler U, Schackert G, Schackert HK. Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun 1999;257:454-9.
8. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818-21.
9. Halliwell B. Reactive oxygen Species and the central nervous system. J Neurochem 1992;59:1609-23.
10. Lee YW, Kuhn H, Hennig B, Neish AS, Toborek M. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol 2001;33:83-94.
11. Zhang Z, Oliver P, Lancaster JR Jr, Schwarzenberger PO, Joshi MS, Cork J. et al. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J 2001;15:303-5.
12. Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S, et al. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol 1998;160:4042-7.
13. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996;21:83-6.
14. Bauer MK, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 1998;273:8048-55.
15. Hug H, Strand S, Grambihler A. Galle J, Hack V, Stremmel W, et al. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 1997;272:28191-3.
16. Vogt M, Bauer MK, Ferrari D, Schulze-Osthoff K. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett 1998;429:67-72.
17. Husain N, Chiocca EA, Rainov N, Louis DN, Zervas, NT. Co-expression of Fas and Fas ligand in malignant glial tumours and cell lines. Acta Neuropathol (Berl) 1998,95:287-90.
18. Kwon D, Choi C, Lee J. Kim KO, Kim JD, Kim SJ, et al. Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis. J Neuroimmunol 2001;113:1-9.
19. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, et al. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell- mediated cytotoxicity. J Immunol 1999;162:2639-47.
20. Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahm YS, et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6,TNT-α, or IFN-γ. J Immunol 1999; 162:1889-95.
21. Furuke K, Shiraishi M, Mostowski HS, Bloom ET. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J Immunol 1999;162:1988-93.
22. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 1994;94:954-64.
23. Rieger J, Ohgaki H, Kleihues P, Weller M. Human astrocytic brain tumors express APO2L/TRAIL. Acta Neuropathol (Berl) 1999;97:1-4.
24. Pyrznska B, Lis A, Mosieniak G, Kaminska B. Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem Int 2001;38:409-15.
25. Ho AM, Jain J, Rao A, Hogan PG. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J Biol Chem 1994;269: 28181-6.
26. Plyte S, Boncristiano M, Fattori E, Galvagni F, Paccani SR, Majolini MB, et al. Identification and characterization of a novel nuclear factor of activated T-cells-1 isoform expressed in mouse brain. J Biol Chem 2001; 276:14350-8.
27. Martinez-Martinez S, Gomez del Arco P, Armesilla AL, Aramburu J, Luo C, Rao A, et al. Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells. Mol Cell Biol 1997;17:6437-47.
28. Saccani S, Saccani A, Varesio L, Ghosh P, Young HA, Sica A. Divergent effect of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur J Immunol 1999;29:1194-201.
29. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Ucken FM. Reactive oxygen intermediates activate NF-κB in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes. Blood 1993;82:1212-20.
30. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am J Physiol 1995;13:L829-36.
31. Leaver HA, Williams JR, Ironside JW, Miller EP, Gregor A, Su BH, et al. Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest 1999;29:220-31.
32. Lee YS, Wurster RD. Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells. Cancer Chemother Pharmacol 1995;36:341-4.